Key Takeaways
- AI is increasingly used to interpret mammograms, enhancing breast cancer detection rates, but radiologists remain skeptical of its reliability.
- A new startup, General Medicine, founded by ex-PillPack employees, has raised $32 million and boasts deep connections with Amazon.
- OpenEvidence and Neuralink are pursuing significant funding, while Viz.ai expands its oncology and COPD care solutions.
Trust Issues in AI for Mammogram Interpretation
Artificial intelligence is making strides in healthcare, particularly in breast cancer screening. AI-assisted mammography has reportedly increased the detection rate of breast cancers. However, a recent study highlighted a continued skepticism among radiologists regarding AI interpretations. While AI can enhance detection, the reluctance of radiologists to fully trust AI findings may hinder improved patient management.
General Medicine Startup with Amazon Ties
General Medicine, a new digital health marketplace founded by three former Amazon employees, has successfully raised $32 million in funding. This startup, which draws upon the foundations laid by the PillPack acquisition by Amazon in 2018, showcases a digital health approach reminiscent of Amazon’s business model. Sunita Mishra, the Chief Medical Officer of Amazon Health Services, has been instrumental in guiding General Medicine’s telehealth strategy.
Industry Highlights
In the realm of health tech funding, OpenEvidence is reportedly engaging with major investors like GV and Kleiner Perkins, aiming to raise over $100 million at a $3 billion valuation. This follows their recent raise of $75 million at a $1 billion valuation. Meanwhile, Elon Musk’s Neuralink is reportedly seeking to secure $600 million at a $9 billion valuation, although this has not yet been confirmed by the company.
Moreover, the Coalition for Health AI has revised its “assurance labs” initiative to better support AI integration in healthcare. Viz.ai continues to expand its offerings as it partners with Sanofi and Regeneron to develop a solution focused on chronic obstructive pulmonary disease (COPD) care.
Recommended Reading
– Inside the Discord community developing its own hair loss drugs, 404 Media
– HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics, STAT
– When people hear voices, but only when they want to, UNDARK
The content above is a summary. For more details, see the source article.